Clearstead Trust LLC Buys New Shares in Danaher Corporation $DHR

Clearstead Trust LLC purchased a new stake in shares of Danaher Corporation (NYSE:DHR) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 3,778 shares of the conglomerate’s stock, valued at approximately $720,000.

Other large investors have also recently bought and sold shares of the company. Norges Bank acquired a new position in shares of Danaher in the 4th quarter valued at about $2,177,106,000. Viking Global Investors LP grew its stake in Danaher by 543.9% during the second quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after purchasing an additional 2,455,994 shares during the period. Wellington Management Group LLP grew its stake in Danaher by 11.2% during the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock worth $3,451,380,000 after purchasing an additional 1,517,904 shares during the period. Capital International Investors increased its holdings in Danaher by 8.9% in the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock worth $4,177,386,000 after purchasing an additional 1,487,768 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in Danaher by 9.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock worth $3,656,595,000 after purchasing an additional 1,334,221 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 0.7%

Shares of NYSE:DHR opened at $202.51 on Friday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80. The business’s 50 day simple moving average is $193.14 and its two-hundred day simple moving average is $193.21. The firm has a market cap of $142.37 billion, a P/E ratio of 35.97, a PEG ratio of 2.52 and a beta of 0.78.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. During the same quarter in the previous year, the company posted $0.77 earnings per share. The company’s quarterly revenue was up 5.5% on a year-over-year basis. As a group, research analysts forecast that Danaher Corporation will post 8.53 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have issued reports on DHR shares. Citigroup assumed coverage on Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target on the stock. DZ Bank initiated coverage on shares of Danaher in a research note on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. Wells Fargo & Company dropped their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. UBS Group cut their target price on shares of Danaher from $270.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Finally, Jefferies Financial Group restated a “buy” rating and issued a $245.00 price target on shares of Danaher in a report on Tuesday, April 21st. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the stock. According to MarketBeat, Danaher currently has an average rating of “Moderate Buy” and a consensus target price of $228.91.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.